Metarmor Overview
- Founded
- 2015
- Status
- Private
- Latest Deal Type
- Angel
- Latest Deal Amount
- $359K
Metarmor General Information
Description
Developer of drug for prevention of hearing loss. The company specializes in developing and commercializing a drug that protects hair cells in the inner ear for prevention of hearing loss and auditory damage.
Contact Information
Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
- 307 North Polktown Road
- Glen Gardner, NJ 08826
- United States
+1 (908) 000-0000
Metarmor Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Angel (individual) | 09-Jun-2017 | $359K | 00000 | Completed | Startup |
Metarmor Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Jennifer Seibert | Chief Executive Officer & Board Member |
Metarmor Board Members (4)
| Name | Representing | Role | Since |
|---|---|---|---|
| Frances Engoron | Metarmor | Board Member | 000 0000 |
| Jennifer Seibert | Metarmor | Chief Executive Officer & Board Member | 000 0000 |
| Joseph Walker | Metarmor | Board Member | 000 0000 |
| Kathleen Campbell | Metarmor | Board Member | 000 0000 |